Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 7,169 shares at $1.58 ($11K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Seasonal sale ($11k) by SVP, Chief Medical Officer — this insider has traded AKBA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2025-02-04 | $163K | — | Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $13K | — | Filing → |